March 2, 2012 — Idiopathic intracranial hypertension (IIH; also called pseudotumor cerebri [PTC] or benign intracranial hypertension) is surprisingly common in patients with systemic lupus ...

Patients with ‘blinding’ headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study, published ...

Patients with 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study, published ...

A drug used for type 2 diabetes may be able to treat those with ‘blinding’ headaches. The corresponding trial was published in Brain. Blinding headaches, also known as idiopathic intracranial ...

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema. (HealthDay News) — For patients with idiopathic intracranial ...

Intracranial hypertension (IH), a clinical condition typically seen in the intensive care unit, is caused by increased pressure surrounding the brain. In many situations, the cause of chronic IH is ...

Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes, may be a potential treatment for idiopathic intracranial hypertension (IIH). In a small phase 2 trial, ...

Although PTC is still often described as benign idiopathic intracranial hypertension, it is actually a very serious condition, and patients may suffer permanent deficits or complications, such as ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Venous manometry and neuroimaging may provide additional value when diagnosing patients who do ...